Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Nov 18, 2016 (10 years ago)

Ropivacaine HCl 0.25% in 0.9% Sodium Chloride

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Ropivacaine HCl 0.25% in 0.9% Sodium Chloride, 100 mL Bag, Epidural Use Only, Rx Only, Cantrell Drug Co. 7321 Cantrell Road Little Rock, AR 72207, NDC 52533-185-75

Affected NDC 52533-0185-75

Compare with the code on your package — it is the most precise check available.

Drug: Ropivacaine

Recalling firm
Cantrell Drug Company
NDC code
52533-185-75
Origin
AR, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0203-2017 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Ropivacaine recalls

See all
Class II · Moderate risk

Fentanyl citrate

CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.

Ongoing cGMP deviation Park Avenue Compounding NDC 83863-4272-1 D-0178-2026

Other recalls by Cantrell Drug Company

All 2016 recalls